These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 16969430)
1. Anidulafungin: a new echinocandin for the treatment of fungal infections. Cohen-Wolkowiez M; Benjamin DK; Steinbach WJ; Smith PB Drugs Today (Barc); 2006 Aug; 42(8):533-44. PubMed ID: 16969430 [TBL] [Abstract][Full Text] [Related]
3. Anidulafungin: a new echinocandin with a novel profile. Vazquez JA Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974 [TBL] [Abstract][Full Text] [Related]
4. Caspofungin: a major breakthrough in treatment of systemic fungal infections. Agarwal MB; Rathi SA; Ratho N; Subramanian R J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012 [TBL] [Abstract][Full Text] [Related]
5. Anidulafungin: review of a new echinocandin antifungal agent. Raasch RH Expert Rev Anti Infect Ther; 2004 Aug; 2(4):499-508. PubMed ID: 15482216 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin. Maschmeyer G; Glasmacher A Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202 [TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of properties and clinical efficacy of the echinocandins. Kim R; Khachikian D; Reboli AC Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730 [TBL] [Abstract][Full Text] [Related]
8. The echinocandins. Cappelletty D; Eiselstein-McKitrick K Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149 [TBL] [Abstract][Full Text] [Related]
9. Echinocandins: the newest class of antifungals. Sucher AJ; Chahine EB; Balcer HE Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014 [TBL] [Abstract][Full Text] [Related]
10. Echinocandin antifungals: review and update. Morrison VA Expert Rev Anti Infect Ther; 2006 Apr; 4(2):325-42. PubMed ID: 16597212 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections. Kuti EL; Kuti JL Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1287-300. PubMed ID: 20822479 [TBL] [Abstract][Full Text] [Related]
12. Anidulafungin, a new echinocandin: effectiveness and tolerability. Menichetti F Drugs; 2009; 69 Suppl 1():95-7. PubMed ID: 19877741 [TBL] [Abstract][Full Text] [Related]
13. Echinocandins: role in antifungal therapy, 2005. Zaas AK; Alexander BD Expert Opin Pharmacother; 2005 Aug; 6(10):1657-68. PubMed ID: 16086652 [TBL] [Abstract][Full Text] [Related]
14. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
15. Management of invasive mycoses in hematology patients: current approaches. Perfect JR Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):5-14. PubMed ID: 15651177 [TBL] [Abstract][Full Text] [Related]
16. Micafungin: the US perspective. Zaas AK; Steinbach WJ Expert Rev Anti Infect Ther; 2005 Apr; 3(2):183-90. PubMed ID: 15918776 [TBL] [Abstract][Full Text] [Related]